STOCKS ARE NOW LOWER ACROSS THE BOARD AS EARNINGS FAIL TO ROUSE INVESTORS
STOCKS TRY TO PUSH TO NEW RECORD HIGHS WEDNESDAY FOLLOWING MIXED EARNINGS NEWS
BOEING STOCK SWINGS HIGHER AFTER EARNINGS, WHICH INCLUDED COSTS FOR 737 MAX
NEED TO KNOW: LATEST STOCK-MARKET RECORDS COULD BE A HEAD FAKE, ANALYST WARNS
BOEING'S STOCK SLIPS AFTER PROFIT MISSES, GUIDANCE DELAYED
OCCIDENTAL SWEEPS IN WITH HIGHER BID FOR ANADARKO THAN CHEVRON IS OFFERING
AT&T SHARES SLIDE AFTER COMPANY'S REVENUE MISSES WALL STREET EXPECTATIONS
WHITE HOUSE MISSES DEADLINE TO TURN OVER TRUMP TAXES TO CONGRESS
TRUMP MET WITH TWITTER CEO JACK DORSEY TODAY TWTR
EBAY STOCK UP 4% AFTER EARNINGS TOP ESTIMATES EBAY

Drug Manufacturers Industry Stocks 0


Screener
Min must be less than the Max.
Name PRICE MARKET CAPITALIZATION PRICE TO EARNINGS RATIO DIVIDEND YIELD SYMBOL EXCHANGE PRICE PERCENT DIFFERENCE YEAR TO DATE PRICE PERCENT DIFFERENCE 5 YEAR CHART 1 YEAR CHART

Aurora Cannabis Inc. Common Shares

ACB $9.14
+0.08 (0.88%)

ACB Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 9.11 Billion
ACB Description

Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis, and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company's purpose-built facilities which integrate technologies across all processes are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year as well as sales and operations in 24 countries worldwide. http://www.auroramj.com

ACB Earnings

EPS -0.25 P/E Ratio 31.99
Previous Earnings Mon, Nov 12, 2018
Latest Earnings Mon, Feb 11, 2019 (72 days ago)

ACB Dividend

Dividend --
Ex-Date --
Pay Date --
History --

ACB Charts

$4.10
52 Week Range
$11.68
Aug 14, 2018
Oct 15, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

9.14 9.11 31.99 0.00 ACB NYSE 0.88 74.43 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ACB&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ACB&exchange=NYSE&chart=1

Aceto Corp

ACET $0.13
-0.05 (-27.78%)

ACET Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 10 Million
ACET Description

Aceto Corp is engaged in the marketing, sells and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, and specialty performance chemicals. Its business is separated into three principal segments: Human Health, Pharmaceutical Ingredients and Performance Chemicals. The company derives most of its revenue from the Human Health segment. http://www.aceto.com

ACET Earnings

EPS -0.63 P/E Ratio 0.00
Previous Earnings Thu, Nov 8, 2018
Latest Earnings Wed, Feb 20, 2019 (63 days ago)

ACET Dividend

Dividend 30.77% / $0.04
Ex-Date Fri, Sep 21, 2018 (215 days ago)
Pay Date Tue, Oct 9, 2018
History 84 Payments (Quarterly)

ACET Charts

$0.13
52 Week Range
$4.18
New Low Today
Jun 20, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

0.13 0.01 0.00 30.77 ACET NASDAQ -27.78 -85.23 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ACET&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ACET&exchange=NASDAQ&chart=1

Adamis Pharmaceuticals Corp

ADMP $2.00
+0.11 (5.82%)

ADMP Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 90 Million
ADMP Description

Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including respiratory disease and allergy. The company's Symjepi (epinephrine) Injection 0.3mg and Symjepi (epinephrine) Injection 0.15 mg products were approved for use in emergency treatment of acute allergic reactions, including anaphylaxis. It previously announced a distribution and commercialization agreement with Sandoz to market Symjepi in the US. The company is developing additional products, including a sublingual tadalafil product candidate for the treatment of erectile dysfunction, a naloxone injection product for the treatment of opioid overdose, and metered dose inhaler and dry powder inhaler product candidates. http://www.adamispharmaceuticals.com

ADMP Earnings

EPS -0.28 P/E Ratio 0.00
Previous Earnings Fri, Aug 10, 2018
Latest Earnings Fri, Nov 9, 2018 (166 days ago)

ADMP Dividend

Dividend --
Ex-Date --
Pay Date --
History --

ADMP Charts

$1.89
52 Week Range
$4.80
Apr 23, 2019
Jul 2, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

2.00 0.09 0.00 0.00 ADMP NASDAQ 5.82 -16.32 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ADMP&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ADMP&exchange=NASDAQ&chart=1

Adamas Pharmaceuticals Inc

ADMS $6.42
+0.05 (0.78%)

ADMS Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 170 Million
ADMS Description

Adamas Pharmaceuticals Inc discovers, develops, and sells therapies for chronic neurologic disorders. The company's approved/commercial product is GOCOVRI, an amantadine therapy for the treatment of levodopa-induced dyskinesia in patients with Parkinson's disease. It operates in one reportable segment: the development and commercialization of therapeutics targeting chronic disorders of the central nervous system. The company generates its revenues primarily from the United States. http://www.adamaspharma.com

ADMS Earnings

EPS -1.06 P/E Ratio 0.00
Previous Earnings Thu, Nov 1, 2018
Latest Earnings Mon, Mar 4, 2019 (51 days ago)

ADMS Dividend

Dividend --
Ex-Date --
Pay Date --
History --

ADMS Charts

$6.28
52 Week Range
$32.67
Apr 18, 2019
May 17, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

6.42 0.17 0.00 0.00 ADMS NASDAQ 0.78 -29.22 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ADMS&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ADMS&exchange=NASDAQ&chart=1

Aerie Pharmaceuticals Inc

AERI $38.51
-1.00 (-2.53%)

AERI Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 1.80 Billion
AERI Description

Aerie Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on discovery, development, and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Its main products are Rhopressa and Roclatan. The company mainly operates in North America. http://www.aeriepharma.com

AERI Earnings

EPS -1.14 P/E Ratio 0.00
Previous Earnings Tue, Nov 6, 2018
Latest Earnings Mon, Feb 25, 2019 (58 days ago)

AERI Dividend

Dividend --
Ex-Date --
Pay Date --
History --

AERI Charts

$33.00
52 Week Range
$73.90
Dec 21, 2018
Jul 19, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

38.51 1.80 0.00 0.00 AERI NASDAQ -2.53 6.03 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=AERI&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=AERI&exchange=NASDAQ&chart=1

Agile Therapeutics Inc

AGRX $1.47
+0.02 (0.69%)

AGRX Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 60 Million
AGRX Description

Agile Therapeutics Inc is a healthcare company dedicated to fulfilling unmet medical needs of today's women. It offers contraceptive options to women which offer greater convenience and facilitate compliance. The company's product candidates include Twirla and Progestin. It has also developed a proprietary technology called Skinfusion. https://www.agiletherapeutics.com

AGRX Earnings

EPS -0.11 P/E Ratio 0.00
Previous Earnings Thu, Nov 1, 2018
Latest Earnings Tue, Mar 12, 2019 (43 days ago)

AGRX Dividend

Dividend --
Ex-Date --
Pay Date --
History --

AGRX Charts

$0.25
52 Week Range
$2.92
Aug 10, 2018
May 1, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

1.47 0.06 0.00 0.00 AGRX NASDAQ 0.69 102.78 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=AGRX&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=AGRX&exchange=NASDAQ&chart=1

Akorn Inc

AKRX $2.88
-0.10 (-3.36%)

AKRX Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 380 Million
AKRX Description

Akorn manufactures ophthalmology and dermatology products as well as injectables. In ophthalmology, the firm primarily sells generic and over-the-counter products but has a small branded portfolio that was purchased from Merck. The firm is primarily focused on the United States. http://www.akorn.com

AKRX Earnings

EPS -1.71 P/E Ratio 0.00
Previous Earnings Thu, Feb 28, 2019
Latest Earnings Tue, May 7, 2019 (In 13 days)

AKRX Dividend

Dividend --
Ex-Date --
Pay Date --
History --

AKRX Charts

$2.77
52 Week Range
$19.51
Apr 18, 2019
Aug 7, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

2.88 0.38 0.00 0.00 AKRX NASDAQ -3.36 -17.24 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=AKRX&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=AKRX&exchange=NASDAQ&chart=1

Alimera Sciences Inc

ALIM $0.88
-0.02 (-2.22%)

ALIM Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 70 Million
ALIM Description

Alimera Sciences Inc is a pharmaceutical company. It specializes in the research, development, and commercialization of prescription ophthalmic pharmaceuticals. The firm focuses on the development of ophthalmic pharmaceuticals for the treatment of diabetic macular edema, wet and dry age-related macular degeneration, and retinal vein occlusion. The product portfolio of the company includes ILUVIEN, which is developed to treat diabetic macular edema. In addition, to the activities related to the development of ILUVIEN, the group is also researching the safety and effectiveness of NADPH (Nicotinamide Adenine Dinucleotide Phosphate) oxidase inhibitors. Geographically it operates through the region of US and also it has its presence in the international market. http://www.alimerasciences.com

ALIM Earnings

EPS -0.02 P/E Ratio 3.96
Previous Earnings Mon, Nov 5, 2018
Latest Earnings Mon, Feb 18, 2019 (65 days ago)

ALIM Dividend

Dividend --
Ex-Date --
Pay Date --
History --

ALIM Charts

$0.72
52 Week Range
$1.19
Dec 31, 2018
Mar 5, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

0.88 0.07 3.96 0.00 ALIM NASDAQ -2.22 3.53 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ALIM&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ALIM&exchange=NASDAQ&chart=1

Alliqua BioMedical Inc

ALQA $2.66
-0.08 (-2.92%)

ALQA Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 10 Million
ALQA Description

Alliqua BioMedical Inc is engaged in the healthcare sector. The company is engaged in developing a suite of advanced wound care solutions that will enable surgeons, clinicians and wound care practitioners to address the challenges in chronic and acute wounds. It utilizes hydrogel technology through which hydrogels are manufactured by introducing a hydrophilic polymer into the water to create a feed mix. http://www.alliqua.com

ALQA Earnings

EPS -0.25 P/E Ratio 0.00
Previous Earnings --
Latest Earnings --

ALQA Dividend

Dividend --
Ex-Date --
Pay Date --
History --

ALQA Charts

$1.63
52 Week Range
$3.52
Nov 23, 2018
Mar 8, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

2.66 0.01 0.00 0.00 ALQA NASDAQ -2.92 33.67 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ALQA&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ALQA&exchange=NASDAQ&chart=1

Amphastar Pharmaceuticals Inc

AMPH $21.01
+0.21 (1.01%)

AMPH Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 940 Million
AMPH Description

Amphastar Pharmaceuticals Inc is a specialty pharmaceutical company engaged in developing, manufacturing, marketing and selling generic and proprietary injectable and inhalation products. The business activities are operated through two reportable segments namely finished pharmaceutical products and API products. The finished pharmaceutical products segment manufactures, markets and distributes enoxaparin, naloxone, lidocaine, as well as various other critical and non-critical care drugs. The API segment manufactures and distributes RHI API and porcine insulin API. Its products are used in hospitals or urgent care clinical settings. Geographically the business presence of the firm is seen in the United States and France of which the US accounts for the majority of revenue. http://www.amphastar.com

AMPH Earnings

EPS 0.04 P/E Ratio 0.00
Previous Earnings Thu, Nov 8, 2018
Latest Earnings Tue, Mar 12, 2019 (43 days ago)

AMPH Dividend

Dividend --
Ex-Date --
Pay Date --
History --

AMPH Charts

$14.63
52 Week Range
$25.28
May 10, 2018
Mar 1, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

21.01 0.94 0.00 0.00 AMPH NASDAQ 1.01 6.33 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=AMPH&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=AMPH&exchange=NASDAQ&chart=1

Amneal Pharmaceuticals Inc

AMRX $12.55
-0.32 (-2.45%)

AMRX Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 3.83 Billion
AMRX Description

Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products and Specialty products. Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. It generates a majority of its revenue from the Generic business segment. https://www.amneal.com

AMRX Earnings

EPS -0.07 P/E Ratio 0.00
Previous Earnings Thu, Feb 28, 2019
Latest Earnings Thu, May 9, 2019 (In 15 days)

AMRX Dividend

Dividend --
Ex-Date --
Pay Date --
History --

AMRX Charts

$11.87
52 Week Range
$24.27
Mar 11, 2019
Aug 20, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

12.55 3.83 0.00 0.00 AMRX NYSE -2.45 -10.99 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=AMRX&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=AMRX&exchange=NYSE&chart=1

Aphria Inc. Common Shares

APHA $7.91
+0.10 (1.28%)

APHA Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 1.92 Billion
APHA Description

Aphria Inc and its subsidiaries produce and sell medical marijuana. Its products include Capsules, Oral solutions, and Vaporizers. The company's operations are based in Leamington, Ontario. It is focused on producing and selling medical marijuana and its derivatives through retail sales and wholesale channels. http://www.aphria.com

APHA Earnings

EPS -0.43 P/E Ratio 32.76
Previous Earnings Fri, Jan 11, 2019
Latest Earnings Mon, Apr 15, 2019 (9 days ago)

APHA Dividend

Dividend --
Ex-Date --
Pay Date --
History --

APHA Charts

$4.51
52 Week Range
$16.50
Dec 4, 2018
Sep 11, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

7.91 1.92 32.76 0.00 APHA NYSE 1.28 31.61 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=APHA&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=APHA&exchange=NYSE&chart=1

Aquinox Pharmaceuticals Inc

AQXP $2.71
+0.05 (1.88%)

AQXP Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 60 Million
AQXP Description

Aquinox Pharmaceuticals Inc is a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology. Its primary focus is anti-inflammatory product candidates targeting SH2-containing inositol-5'-phosphatase 1, or SHIP1, which is a regulator of a cellular signaling pathway in immune cells. The company's product candidate includes AQX-1125, which is a small molecule activator of SHIP1 suitable for oral, once daily dosing. The company is developing AQX-1125 as a treatment in interstitial cystitis/bladder pain syndrome, a chronic inflammatory disease of the bladder. All the business activity of the group is functioned through United States. http://www.aqxpharma.com

AQXP Earnings

EPS -0.20 P/E Ratio 0.00
Previous Earnings Wed, Aug 8, 2018
Latest Earnings Wed, Nov 7, 2018 (168 days ago)

AQXP Dividend

Dividend --
Ex-Date --
Pay Date --
History --

AQXP Charts

$2.07
52 Week Range
$15.72
Dec 28, 2018
Jun 18, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

2.71 0.06 0.00 0.00 AQXP NASDAQ 1.88 15.88 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=AQXP&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=AQXP&exchange=NASDAQ&chart=1

Aradigm Corp

ARDM $0.12
-0.34 (-73.91%)

ARDM Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 10 Million
ARDM Description

Aradigm Corp is a United States based specialty pharmaceutical company. It develops and commercializes drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases. The company has respiratory inhalation products in preclinical and clinical development for the treatment of cystic fibrosis, bronchiectasis, biodefense, and tobacco smoking cessation. It derives revenue from the grants, collaboration agreements, and feasibility studies. http://www.aradigm.com

ARDM Earnings

EPS -0.24 P/E Ratio 0.00
Previous Earnings --
Latest Earnings --

ARDM Dividend

Dividend --
Ex-Date --
Pay Date --
History --

ARDM Charts

$0.12
52 Week Range
$1.93
Feb 19, 2019
Jun 20, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

0.12 0.01 0.00 0.00 ARDM NASDAQ -73.91 -67.57 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ARDM&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ARDM&exchange=NASDAQ&chart=1

Assertio Therapeutics, Inc. - Common Stock

ASRT $4.37
+0.01 (0.23%)

ASRT Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 270 Million
ASRT Description

Assertio Therapeutics Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid filled capsules for relief of mild to moderate pain. https://www.assertiotx.com

ASRT Earnings

EPS -0.38 P/E Ratio 10.24
Previous Earnings Thu, Nov 8, 2018
Latest Earnings Wed, Mar 6, 2019 (49 days ago)

ASRT Dividend

Dividend --
Ex-Date --
Pay Date --
History --

ASRT Charts

$3.53
52 Week Range
$9.33
Dec 27, 2018
Aug 7, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

4.37 0.27 10.24 0.00 ASRT NASDAQ 0.23 9.80 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ASRT&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ASRT&exchange=NASDAQ&chart=1

Avenue Therapeutics Inc

ATXI $4.79
+0.22 (4.81%)

ATXI Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 80 Million
ATXI Description

Avenue Therapeutics Inc is a specialty pharmaceutical company. It is focused on the development and commercialization of an intravenous, or IV, formulation of tramadol HCl, or IV Tramadol, for the management of moderate to moderately severe postoperative pain. The company's primary objective is to establish IV Tramadol as an invaluable part of a treating physician's repertoire of available pharmaceutical options for the management of postoperative pain. http://www.avenuetx.com

ATXI Earnings

EPS -0.63 P/E Ratio 0.00
Previous Earnings Wed, Nov 14, 2018
Latest Earnings Tue, Mar 12, 2019 (43 days ago)

ATXI Dividend

Dividend --
Ex-Date --
Pay Date --
History --

ATXI Charts

$2.10
52 Week Range
$6.59
Oct 10, 2018
Jan 18, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

4.79 0.08 0.00 0.00 ATXI NASDAQ 4.81 -13.69 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ATXI&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ATXI&exchange=NASDAQ&chart=1

Astrazeneca PLC Common Stock

AZN $38.88
+0.19 (0.49%)

AZN Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 101.79 Billion
AZN Description

AstraZeneca PLC is a merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The company sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology, and neuroscience. The majority of sales come from international markets with the United States representing close to 30% of its sales. http://www.astrazeneca.com

AZN Earnings

EPS 0.41 P/E Ratio 46.84
Previous Earnings Thu, Feb 14, 2019
Latest Earnings Fri, Apr 26, 2019 (In 2 days)

AZN Dividend

Dividend 2.32% / $0.90
Ex-Date Thu, Aug 9, 2018 (258 days ago)
Pay Date Mon, Sep 10, 2018
History 51 Payments (Biannual)

AZN Charts

$34.55
52 Week Range
$43.02
Jun 27, 2018
Mar 20, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

38.88 101.79 46.84 2.32 AZN NYSE 0.49 2.86 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=AZN&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=AZN&exchange=NYSE&chart=1

Bausch Health Companies Inc. Common Stock

BHC $23.36
-0.11 (-0.47%)

BHC Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 8.05 Billion
BHC Description

Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. https://www.bauschhealth.com

BHC Earnings

EPS -0.98 P/E Ratio 0.00
Previous Earnings Wed, Feb 20, 2019
Latest Earnings Mon, May 6, 2019 (In 12 days)

BHC Dividend

Dividend --
Ex-Date --
Pay Date --
History 22 Payments (Quarterly)

BHC Charts

$17.47
52 Week Range
$28.32
Apr 24, 2018
Oct 3, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

23.36 8.05 0.00 0.00 BHC NYSE -0.47 15.47 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BHC&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BHC&exchange=NYSE&chart=1

Benitec Biopharma Limited - American Depositary Shares

BNTC $1.74
-0.01 (-0.57%)

BNTC Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 20 Million
BNTC Description

Benitec Biopharma Ltd is active in the healthcare domain. The company is engaged in commercialization of its Intellectual Property, It focusses on development of its therapeutic pipeline and pre-clinical programs, and funding, and protecting and building the IP estate. It has a pipeline of in-house and partnered therapeutic programs based on its patented gene-silencing technology, deoxyribonucleic acid directed ribonucleic acid interference. http://www.benitec.com

BNTC Earnings

EPS -0.27 P/E Ratio 18.11
Previous Earnings --
Latest Earnings --

BNTC Dividend

Dividend --
Ex-Date --
Pay Date --
History --

BNTC Charts

$1.15
52 Week Range
$3.35
Dec 24, 2018
Jul 9, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

1.74 0.02 18.11 0.00 BNTC NASDAQ -0.57 16.00 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BNTC&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BNTC&exchange=NASDAQ&chart=1

Bio-Path Holdings Inc

BPTH $18.67
+0.62 (3.43%)

BPTH Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 50 Million
BPTH Description

Bio-Path Holdings Inc is a United States based clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease. The company's lead drug candidate, prexigebersen, is in the efficacy portion of a Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and in combination with decitabine. The other drug candidates of the company are BP1002 and BP1003. http://www.biopathholdings.com

BPTH Earnings

EPS -2.58 P/E Ratio 0.00
Previous Earnings --
Latest Earnings Wed, Mar 20, 2019 (35 days ago)

BPTH Dividend

Dividend --
Ex-Date --
Pay Date --
History --

BPTH Charts

$1.75
52 Week Range
$38.86
Jan 18, 2019
Mar 7, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

18.67 0.05 0.00 0.00 BPTH NASDAQ 3.43 391.32 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BPTH&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BPTH&exchange=NASDAQ&chart=1

Canopy Growth Corporation Common Stock

CGC $48.64
+1.23 (2.60%)

CGC Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 15.28 Billion
CGC Description

Canopy Growth Corp through its subsidiaries is the licensed producer of medical marijuana in Canada. The company grows, produces and sells medical marijuana. It operates diverse brands and variety supported by over half million square feet of indoor and greenhouse marijuana production. It sells medical marijuana under various brand names including Tweed, Bedrocan, and Mettrum. A majority of the revenue is derived from the sale of medical marijuana by Tweed and Bedrocan in Canada. http://www.canopygrowth.com

CGC Earnings

EPS 0.22 P/E Ratio 0.00
Previous Earnings Wed, Nov 14, 2018
Latest Earnings Mon, Jan 14, 2019 (100 days ago)

CGC Dividend

Dividend --
Ex-Date --
Pay Date --
History --

CGC Charts

$21.11
52 Week Range
$56.89
Apr 26, 2018
Oct 15, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

48.64 15.28 0.00 0.00 CGC NYSE 2.60 67.29 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CGC&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CGC&exchange=NYSE&chart=1

Collegium Pharmaceutical Inc

COLL $14.82
-0.01 (-0.07%)

COLL Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 470 Million
COLL Description

Collegium Pharmaceutical Inc is a US-based specialty pharmaceutical company. It is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing and dissolving. The company's product Xtampza ER, is an abuse-deterrent, extended-release, oral formulation of oxycodone. http://www.collegiumpharma.com

COLL Earnings

EPS 0.27 P/E Ratio 0.00
Previous Earnings Thu, Nov 8, 2018
Latest Earnings Wed, Feb 27, 2019 (56 days ago)

COLL Dividend

Dividend --
Ex-Date --
Pay Date --
History --

COLL Charts

$13.52
52 Week Range
$28.29
Apr 18, 2019
Jun 20, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

14.82 0.47 0.00 0.00 COLL NASDAQ -0.07 -16.57 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=COLL&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=COLL&exchange=NASDAQ&chart=1

Correvio Pharma Corp. - Ordinary Shares (Canada)

CORV $2.67
0.00 (0.00%)

CORV Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 110 Million
CORV Description

Correvio Pharma Corp, formerly Cardiome Pharma Corp is specialty pharmaceutical company. It offers patients and healthcare providers therapeutic solutions for acute medical conditions to improve health and quality of life. Its products are AGGRASTAT, EXEMBOL, BRINAVESS and others. The firm earns revenue from the sale of company's commercialized products. It has Europe and Rest of the world geographic segments. https://www.correvio.com

CORV Earnings

EPS -0.39 P/E Ratio 0.00
Previous Earnings Tue, Nov 6, 2018
Latest Earnings Wed, Mar 13, 2019 (42 days ago)

CORV Dividend

Dividend --
Ex-Date --
Pay Date --
History --

CORV Charts

$2.07
52 Week Range
$25.50
Jun 6, 2018
May 17, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

2.67 0.11 0.00 0.00 CORV NASDAQ 0.00 9.43 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CORV&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CORV&exchange=NASDAQ&chart=1

Cumberland Pharmaceuticals Inc

CPIX $5.73
-0.18 (-3.05%)

CPIX Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 90 Million
CPIX Description

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It focuses on the acquisition, development, and commercialization of branded prescription products. The company provides prescription products to hospital acute care and gastroenterology to address unmet or poorly met medical needs. Its product brands include Acetadote, Caldolor, Kristalose, Omeclamox- Pak, Vaprisol and Ethyol. http://www.cumberlandpharma.com

CPIX Earnings

EPS -0.14 P/E Ratio 0.00
Previous Earnings Tue, Nov 13, 2018
Latest Earnings Tue, Feb 26, 2019 (57 days ago)

CPIX Dividend

Dividend --
Ex-Date --
Pay Date --
History --

CPIX Charts

$5.06
52 Week Range
$7.00
Feb 28, 2019
Nov 14, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

5.73 0.09 0.00 0.00 CPIX NASDAQ -3.05 -11.02 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CPIX&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CPIX&exchange=NASDAQ&chart=1

Catalyst Pharmaceuticals Inc

CPRX $5.39
-0.01 (-0.19%)

CPRX Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 550 Million
CPRX Description

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with lambert-eaton myasthenic syndrome. http://www.catalystpharma.com

CPRX Earnings

EPS -0.14 P/E Ratio 0.00
Previous Earnings Wed, Nov 7, 2018
Latest Earnings Mon, Mar 18, 2019 (37 days ago)

CPRX Dividend

Dividend --
Ex-Date --
Pay Date --
History --

CPRX Charts

$1.92
52 Week Range
$5.60
Dec 31, 2018
Apr 5, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

5.39 0.55 0.00 0.00 CPRX NASDAQ -0.19 155.45 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CPRX&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CPRX&exchange=NASDAQ&chart=1

Cronos Group Inc. - Common Share

CRON $16.90
+0.62 (3.81%)

CRON Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 5.17 Billion
CRON Description

Cronos Group Inc is a diversified and vertically integrated cannabis company. Its principal activities involve production and sale of cannabis in federally legal jurisdictions, including Canada and Germany. The company sells dried cannabis and cannabis oils under its medical cannabis brand Peace Naturals. It seeks to invest in companies either licensed or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations. The company other brands include Spinach and Cove. http://www.thecronosgroup.com

CRON Earnings

EPS -0.07 P/E Ratio 0.00
Previous Earnings Tue, Mar 26, 2019
Latest Earnings Thu, May 9, 2019 (In 15 days)

CRON Dividend

Dividend --
Ex-Date --
Pay Date --
History --

CRON Charts

$5.52
52 Week Range
$23.70
May 9, 2018
Mar 5, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

16.90 5.17 0.00 0.00 CRON NASDAQ 3.81 49.43 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CRON&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CRON&exchange=NASDAQ&chart=1

Catalent Inc

CTLT $44.21
-0.24 (-0.54%)

CTLT Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 6.34 Billion
CTLT Description

Catalent is a specialty and generic drug manufacturing company. The company focuses on advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. The vast majority of Catalent's sales are generated in the United States, followed by Europe and the rest of the world. Most of the company's sales are derived from branded drug products. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. http://www.catalent.com

CTLT Earnings

EPS 0.34 P/E Ratio 43.53
Previous Earnings Tue, Feb 5, 2019
Latest Earnings Tue, May 7, 2019 (In 13 days)

CTLT Dividend

Dividend --
Ex-Date --
Pay Date --
History --

CTLT Charts

$29.84
52 Week Range
$46.34
Jan 3, 2019
Oct 3, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

44.21 6.34 43.53 0.00 CTLT NYSE -0.54 43.03 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CTLT&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CTLT&exchange=NYSE&chart=1

Diplomat Pharmacy Inc

DPLO $5.47
+0.04 (0.74%)

DPLO Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 410 Million
DPLO Description

Diplomat Pharmacy Inc is active within the United States healthcare sector. It offers a range of services related to medical care, especially pharmacy solutions for chronic diseases. Its Specialty segment operates in dispensing prescription drugs for home delivery at the time the drugs are physically delivered which is the point in time when control transfers to the customer. PBM segment provides pharmacy benefit management services, including mail order pharmacy and specialty pharmacy services, to its clients, which include Medicare Part D Plans, regional health Plans, self-insured clients and Medicaid Plans, which culminates in the dispensing of prescription drugs. It derives most of its revenue through prescription drug sales in the United States. http://www.diplomat.is

DPLO Earnings

EPS -4.00 P/E Ratio 374.25
Previous Earnings Mon, Feb 25, 2019
Latest Earnings Tue, May 7, 2019 (In 13 days)

DPLO Dividend

Dividend --
Ex-Date --
Pay Date --
History --

DPLO Charts

$5.21
52 Week Range
$28.13
Apr 17, 2019
Jun 22, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

5.47 0.41 374.25 0.00 DPLO NYSE 0.74 -60.30 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=DPLO&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=DPLO&exchange=NYSE&chart=1

Durect Corp

DRRX $0.60
+0.04 (5.34%)

DRRX Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 100 Million
DRRX Description

Durect Corp is a biopharmaceutical company. It is engaged in the research, development and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and drug delivery programs. The company's pipeline products consist of DUR-928, RBP-7000, Remoxy, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan and other countries, of which key revenue is derived from Europe and the US. http://www.durect.com

DRRX Earnings

EPS -0.05 P/E Ratio 0.00
Previous Earnings Wed, Nov 7, 2018
Latest Earnings Thu, Mar 7, 2019 (48 days ago)

DRRX Dividend

Dividend --
Ex-Date --
Pay Date --
History --

DRRX Charts

$0.48
52 Week Range
$2.20
Dec 31, 2018
Jun 15, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

0.60 0.10 0.00 0.00 DRRX NASDAQ 5.34 7.41 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=DRRX&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=DRRX&exchange=NASDAQ&chart=1

Eagle Pharmaceuticals Inc

EGRX $52.01
-0.04 (-0.06%)

EGRX Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 670 Million
EGRX Description

Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, docetaxel injection, non-alcohol formulation and Bendeka. The company currently have multiple product candidates in advanced stages of development, and under review for approval by the Food and Drug Administration. http://www.eagleus.com

EGRX Earnings

EPS 0.86 P/E Ratio 26.46
Previous Earnings Thu, Nov 1, 2018
Latest Earnings Thu, Feb 28, 2019 (55 days ago)

EGRX Dividend

Dividend --
Ex-Date --
Pay Date --
History --

EGRX Charts

$36.72
52 Week Range
$83.86
Dec 24, 2018
Jul 19, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

52.01 0.67 26.46 0.00 EGRX NASDAQ -0.06 28.57 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=EGRX&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=EGRX&exchange=NASDAQ&chart=1

Elanco Animal Health Inc

ELAN $31.63
-0.01 (-0.02%)

ELAN Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 11.38 Billion
ELAN Description

Elanco Animal Health Inc is a animal health company which is engaged in innovating, developing, manufacturing, and marketing products for companion and food animals. Geographically, the company derives revenue from North America, Europe, the Middle East and Africa, Latin America, and Asia Pacific with highest revenue from North America segment. http://www.elanco.com

ELAN Earnings

EPS 0.04 P/E Ratio 0.00
Previous Earnings Wed, Feb 13, 2019
Latest Earnings Tue, Apr 30, 2019 (In 6 days)

ELAN Dividend

Dividend --
Ex-Date --
Pay Date --
History --

ELAN Charts

$29.00
52 Week Range
$36.19
Feb 25, 2019
Sep 27, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

31.63 11.38 0.00 0.00 ELAN NYSE -0.02 -0.38 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ELAN&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ELAN&exchange=NYSE&chart=1

Evolus Inc

EOLS $26.94
+1.00 (3.86%)

EOLS Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 660 Million
EOLS Description

Evolus Inc is engaged in providing physicians and their patients with expanded choices in medical aesthetic treatments and procedures. Its product candidate is an injectable formulation of a 900 kDa Botulinum toxin Type A complex. It has also completed the development program for DWP-450 for the treatment of moderate to severe glabellar lines. https://www.evolus.com

EOLS Earnings

EPS -0.46 P/E Ratio 0.00
Previous Earnings Mon, Nov 5, 2018
Latest Earnings Mon, Mar 18, 2019 (37 days ago)

EOLS Dividend

Dividend --
Ex-Date --
Pay Date --
History --

EOLS Charts

$6.85
52 Week Range
$38.49
Apr 30, 2018
Jun 6, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

26.94 0.66 0.00 0.00 EOLS NASDAQ 3.86 116.73 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=EOLS&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=EOLS&exchange=NASDAQ&chart=1

ESSA Pharma Inc. - Common Stock

EPIX $2.35
+0.05 (2.17%)

EPIX Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 10 Million
EPIX Description

ESSA Pharma Inc is a pharmaceutical company. The company is in preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs which selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. http://www.essapharma.com

EPIX Earnings

EPS -0.43 P/E Ratio 0.00
Previous Earnings --
Latest Earnings Tue, Aug 14, 2018 (253 days ago)

EPIX Dividend

Dividend --
Ex-Date --
Pay Date --
History --

EPIX Charts

$1.90
52 Week Range
$4.74
Dec 20, 2018
May 1, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

2.35 0.01 0.00 0.00 EPIX NASDAQ 2.17 11.90 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=EPIX&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=EPIX&exchange=NASDAQ&chart=1

Evoke Pharma Inc

EVOK $0.72
+0.01 (1.41%)

EVOK Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 10 Million
EVOK Description

Evoke Pharma Inc is a specialty pharmaceutical company based in the United States. It focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. The company is engaged in developing an investigational metoclopramide nasal spray called Gimoti, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel formulation of drug which is designed to provide systemic delivery of metoclopramide through nasal spray administration to treat the symptoms associated with acute and recurrent diabetic gastroparesis and it is also available in oral tablet and injection dose forms. The company primarily operates in the US. http://www.evokepharma.com

EVOK Earnings

EPS -0.02 P/E Ratio 0.00
Previous Earnings Thu, Aug 9, 2018
Latest Earnings Tue, Nov 13, 2018 (162 days ago)

EVOK Dividend

Dividend --
Ex-Date --
Pay Date --
History --

EVOK Charts

$0.71
52 Week Range
$3.33
Apr 23, 2019
Sep 17, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

0.72 0.01 0.00 0.00 EVOK NASDAQ 1.41 -71.76 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=EVOK&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=EVOK&exchange=NASDAQ&chart=1

Fibrocell Science Inc

FCSC $2.27
+0.05 (2.25%)

FCSC Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 20 Million
FCSC Description

Fibrocell Science Inc is active in the healthcare sector. It is an autologous cell and gene therapy company focused on discovering and developing localized therapies for diseases affecting the skin, connective tissue, and joints. Its gene-therapy product candidate, FCX-007, is in pre-clinical development for the treatment of recessive dystrophic epidermolysis bullosa and its gene-therapy product candidate, FCX-013, is in pre-clinical development for the treatment of linear scleroderma. https://www.fibrocell.com

FCSC Earnings

EPS -0.14 P/E Ratio 0.00
Previous Earnings --
Latest Earnings --

FCSC Dividend

Dividend --
Ex-Date --
Pay Date --
History --

FCSC Charts

$1.50
52 Week Range
$4.80
Dec 21, 2018
May 17, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

2.27 0.02 0.00 0.00 FCSC NASDAQ 2.25 37.58 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=FCSC&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=FCSC&exchange=NASDAQ&chart=1

Flexion Therapeutics Inc

FLXN $10.73
-0.01 (-0.09%)

FLXN Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 390 Million
FLXN Description

Flexion Therapeutics Inc is a United States-based specialty pharmaceutical company. The company focuses on the development and commercialization of novel, local therapies. The company specializes in the treatment of patients with musculoskeletal conditions beginning with osteoarthritis. The products offered by company are zilretta which is used for enhancing clinical effect of intra articular corticosteroid treatment. http://www.flexiontherapeutics.com

FLXN Earnings

EPS -1.07 P/E Ratio 0.00
Previous Earnings Wed, Nov 7, 2018
Latest Earnings Thu, Feb 28, 2019 (55 days ago)

FLXN Dividend

Dividend --
Ex-Date --
Pay Date --
History --

FLXN Charts

$10.22
52 Week Range
$28.14
Apr 18, 2019
Jun 20, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

10.73 0.39 0.00 0.00 FLXN NASDAQ -0.09 -13.88 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=FLXN&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=FLXN&exchange=NASDAQ&chart=1

Galectin Therapeutics Inc

GALT $4.71
+0.09 (1.95%)

GALT Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 200 Million
GALT Description

Galectin Therapeutics Inc is a biotechnology company. The company is focused on discovery and development. It is engaged in galectin science and drug development to create new therapies to improve the lives of patients with chronic liver and skin diseases and cancer. Drug candidates based on carbohydrate technology target galectin proteins, which are key mediators of biologic and pathologic function. Galectin Therapeutics is pursuing therapies for indications in which galectins have a demonstrated role in the pathogenesis of directly involved in multiple inflammatory, fibrotic, and malignant diseases. The lead development program is in non-alcoholic steatohepatitis (NASH) with cirrhosis, the most advanced form of NASH-related fibrosis. http://www.galectintherapeutics.com

GALT Earnings

EPS -0.08 P/E Ratio 0.00
Previous Earnings Tue, Nov 13, 2018
Latest Earnings Wed, Mar 6, 2019 (49 days ago)

GALT Dividend

Dividend --
Ex-Date --
Pay Date --
History --

GALT Charts

$3.16
52 Week Range
$9.16
Apr 24, 2018
Jun 18, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

4.71 0.20 0.00 0.00 GALT NASDAQ 1.95 22.02 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=GALT&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=GALT&exchange=NASDAQ&chart=1

GlaxoSmithKline PLC Common Stock

GSK $39.94
-0.28 (-0.70%)

GSK Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 98.95 Billion
GSK Description

GlaxoSmithKline PLC in the pharmaceutical industry ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory and antiviral, as well as vaccines and consumer healthcare products. http://www.gsk.com

GSK Earnings

EPS 0.49 P/E Ratio 40.40
Previous Earnings Wed, Feb 6, 2019
Latest Earnings Wed, May 1, 2019 (In 7 days)

GSK Dividend

Dividend 5.98% / $2.39
Ex-Date Thu, Feb 21, 2019 (62 days ago)
Pay Date Thu, Apr 11, 2019
History 108 Payments (Quarterly)

GSK Charts

$37.07
52 Week Range
$41.94
Dec 17, 2018
Jun 14, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

39.94 98.95 40.40 5.98 GSK NYSE -0.70 5.44 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=GSK&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=GSK&exchange=NYSE&chart=1

GW Pharmaceuticals Plc - American Depositary Shares

GWPH $163.48
-2.08 (-1.26%)

GWPH Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 4.77 Billion
GWPH Description

GW Pharmaceuticals PLC is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. Its business activities are functioned through three reportable segments which are Commercial, Sativex Research and Development and Pipeline Research and Development. The company's lead product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol used for the treatment of a number of rare childhood-onset epilepsy disorders. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. Geographically its presence can be seen across the region of UK, Europe, US, Canada, and others. http://www.gwpharm.com

GWPH Earnings

EPS -2.40 P/E Ratio 0.00
Previous Earnings Tue, Nov 27, 2018
Latest Earnings Tue, Feb 26, 2019 (57 days ago)

GWPH Dividend

Dividend --
Ex-Date --
Pay Date --
History --

GWPH Charts

$94.36
52 Week Range
$177.34
Dec 27, 2018
Mar 1, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

163.48 4.77 0.00 0.00 GWPH NASDAQ -1.26 62.65 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=GWPH&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=GWPH&exchange=NASDAQ&chart=1

Hutchison China MediTech Limited - American Depositary Shares

HCM $29.79
+0.07 (0.24%)

HCM Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 4.05 Billion
HCM Description

Hutchison China Meditech Ltd is a major drug manufacturing company. The company operates two platforms- an innovation platform and a commercial platform. Hutchison's innovation platform focuses on discovering and developing therapeutics in oncology and autoimmune diseases. The company's commercial platform includes the manufacturing, marketing, and distribution of prescription and over-the-counter pharmaceuticals in China as well as certain consumer products in Hong Kong. The vast majority of the company's revenue is generated through its commercial platform. http://www.chi-med.com

HCM Earnings

EPS 0.00 P/E Ratio 0.00
Previous Earnings --
Latest Earnings Mon, Mar 11, 2019 (44 days ago)

HCM Dividend

Dividend --
Ex-Date --
Pay Date --
History --

HCM Charts

$21.27
52 Week Range
$37.69
Jan 14, 2019
Nov 14, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

29.79 4.05 0.00 0.00 HCM NASDAQ 0.24 30.66 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=HCM&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=HCM&exchange=NASDAQ&chart=1

Heron Therapeutics Inc

HRTX $23.91
-0.19 (-0.79%)

HRTX Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 1.80 Billion
HRTX Description

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL and CINVANTI. Its pipeline product is HTX-011. http://www.herontx.com

HRTX Earnings

EPS -0.63 P/E Ratio 0.00
Previous Earnings Wed, Nov 7, 2018
Latest Earnings Fri, Feb 22, 2019 (61 days ago)

HRTX Dividend

Dividend --
Ex-Date --
Pay Date --
History --

HRTX Charts

$22.03
52 Week Range
$42.00
Dec 24, 2018
Jun 27, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

23.91 1.80 0.00 0.00 HRTX NASDAQ -0.79 -8.04 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=HRTX&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=HRTX&exchange=NASDAQ&chart=1

Horizon Pharma PLC

HZNP $25.45
+0.19 (0.75%)

HZNP Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 4.60 Billion
HZNP Description

Horizon Pharma is a specialty and generic drug manufacturing company. The company is focused on the identification, development, acquisition, and commercialization of differentiated and accessible medicines that address unmet medical needs. The overwhelming majority of revenue is generated in the United States. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. https://www.horizonpharma.com

HZNP Earnings

EPS 0.52 P/E Ratio 0.00
Previous Earnings Wed, Feb 27, 2019
Latest Earnings Wed, May 8, 2019 (In 14 days)

HZNP Dividend

Dividend --
Ex-Date --
Pay Date --
History --

HZNP Charts

$13.24
52 Week Range
$29.01
Apr 30, 2018
Feb 28, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

25.45 4.60 0.00 0.00 HZNP NASDAQ 0.75 27.70 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=HZNP&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=HZNP&exchange=NASDAQ&chart=1

Imprimis Pharmaceuticals Inc

IMMY $5.69
+0.50 (9.63%)

IMMY Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 130 Million
IMMY Description

Imprimis Pharmaceuticals Inc is an ophthalmology-focused pharmaceutical company. The company is specialized in the development, production, and sale of medications that offer competitive advantages and serve unmet needs in the marketplace. Its cornerstone of ophthalmology program consists of proprietary Dropless Therapy injectable and LessDrops topical formulations that are designed to address patient compliance issues and provide other compelling medical and economic benefits. http://www.imprimispharma.com

IMMY Earnings

EPS -0.12 P/E Ratio 0.00
Previous Earnings Mon, Aug 6, 2018
Latest Earnings Tue, Nov 13, 2018 (162 days ago)

IMMY Dividend

Dividend --
Ex-Date --
Pay Date --
History --

IMMY Charts

$2.14
52 Week Range
$6.11
May 29, 2018
Dec 12, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

5.69 0.13 0.00 0.00 IMMY NASDAQ 9.63 -98.30 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=IMMY&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=IMMY&exchange=NASDAQ&chart=1

Ironwood Pharmaceuticals Inc

IRWD $12.02
+0.02 (0.17%)

IRWD Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 1.74 Billion
IRWD Description

Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. http://www.ironwoodpharma.com

IRWD Earnings

EPS -0.10 P/E Ratio 0.00
Previous Earnings Wed, Feb 13, 2019
Latest Earnings Thu, May 2, 2019 (In 8 days)

IRWD Dividend

Dividend --
Ex-Date --
Pay Date --
History --

IRWD Charts

$7.79
52 Week Range
$17.64
Dec 21, 2018
Jul 17, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

12.02 1.74 0.00 0.00 IRWD NASDAQ 0.17 38.32 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=IRWD&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=IRWD&exchange=NASDAQ&chart=1

Karyopharm Therapeutics Inc

KPTI $4.97
-0.01 (-0.20%)

KPTI Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 280 Million
KPTI Description

Karyopharm Therapeutics Inc., is a clinical-stage pharmaceutical company focused on the discovery, development and subsequent commercialization of novel, first-in-class drugs directed against nuclear transport and related targets for the treatment of cancer and other major diseases. The company has discovered and is developing small molecule Selective Inhibitor of Nuclear Export (SINE) compounds that inhibit the nuclear export protein, XPO1. Karyopharm's lead drug candidate, selinexor (KPT-330), is an orally administered agent for the treatment of cancer indications with unmet clinical need, mainly hematologic malignancies. It is also engaged in the clinical development of selinexor in various solid tumor indications. http://www.karyopharm.com

KPTI Earnings

EPS -0.97 P/E Ratio 0.00
Previous Earnings Thu, Nov 8, 2018
Latest Earnings Thu, Feb 28, 2019 (55 days ago)

KPTI Dividend

Dividend --
Ex-Date --
Pay Date --
History --

KPTI Charts

$4.12
52 Week Range
$21.18
Mar 11, 2019
Aug 30, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

4.97 0.28 0.00 0.00 KPTI NASDAQ -0.20 -48.01 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=KPTI&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=KPTI&exchange=NASDAQ&chart=1

Lannett Co Inc

LCI $7.28
+0.08 (1.11%)

LCI Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 280 Million
LCI Description

Lannett Co Inc develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products. It offers solid oral, extended release, topical, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, soft gel, and injectable dosages. In addition, the company also provides its products for various medical indications comprising glaucoma, gastrointestinal, migraine, obesity, respiratory and others. It operates in the segment of generic pharmaceuticals. Its customers include generic pharmaceutical distributors, drug wholesalers, chain drug stores, private label distributors, mail-order pharmacies, and others. http://www.lannett.com

LCI Earnings

EPS 0.33 P/E Ratio 0.00
Previous Earnings Wed, Nov 7, 2018
Latest Earnings Wed, Feb 6, 2019 (77 days ago)

LCI Dividend

Dividend --
Ex-Date --
Pay Date --
History --

LCI Charts

$3.43
52 Week Range
$17.05
Oct 24, 2018
May 21, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

7.28 0.28 0.00 0.00 LCI NYSE 1.11 36.07 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=LCI&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=LCI&exchange=NYSE&chart=1

Lipocine Inc

LPCN $1.84
-0.01 (-0.54%)

LPCN Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 40 Million
LPCN Description

Lipocine Inc is a specialty pharmaceutical company focused on the development of pharmaceutical products in the area of men's and women's health. Its primary development programs are based on oral delivery solutions for poorly bioavailable drugs. The company has a portfolio of product candidates designed to produce pharmacokinetic characteristics, facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. Its principal product candidate is TLANDO, an oral testosterone replacement therapy. http://www.lipocine.com

LPCN Earnings

EPS -0.15 P/E Ratio 0.00
Previous Earnings Wed, Nov 7, 2018
Latest Earnings Wed, Mar 6, 2019 (49 days ago)

LPCN Dividend

Dividend --
Ex-Date --
Pay Date --
History --

LPCN Charts

$1.06
52 Week Range
$2.33
May 10, 2018
Mar 28, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

1.84 0.04 0.00 0.00 LPCN NASDAQ -0.54 26.03 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=LPCN&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=LPCN&exchange=NASDAQ&chart=1

The Medicines Co

MDCO $29.51
+0.14 (0.48%)

MDCO Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 2.07 Billion
MDCO Description

The Medicines Company is a pharmaceutical firm that provides products to the U.S. hospital market. The company's primary commercial product, Angiomax, is an anticoagulant drug used in conjunction with aspirin for patients undergoing angioplasty. Medicines recently commercialized a new drug, Cleviprex, which is designed to control blood pressure in intensive-care settings. https://www.themedicinescompany.com

MDCO Earnings

EPS -0.58 P/E Ratio 0.00
Previous Earnings Wed, Feb 27, 2019
Latest Earnings Thu, Apr 25, 2019 (In 1 days)

MDCO Dividend

Dividend --
Ex-Date --
Pay Date --
History --

MDCO Charts

$17.26
52 Week Range
$40.94
Dec 21, 2018
Aug 29, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

29.51 2.07 0.00 0.00 MDCO NASDAQ 0.48 58.91 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=MDCO&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=MDCO&exchange=NASDAQ&chart=1

MEI Pharma Inc

MEIP $3.05
-0.03 (-0.66%)

MEIP Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 210 Million
MEIP Description

MEI Pharma Inc is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes ME-401, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer. Geographically, all the business activities are functioned through the region of US. http://www.meipharma.com

MEIP Earnings

EPS 0.17 P/E Ratio 0.00
Previous Earnings Thu, Nov 8, 2018
Latest Earnings Thu, Feb 7, 2019 (76 days ago)

MEIP Dividend

Dividend --
Ex-Date --
Pay Date --
History --

MEIP Charts

$1.92
52 Week Range
$4.95
Dec 24, 2018
Jun 8, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

3.05 0.21 0.00 0.00 MEIP NASDAQ -0.66 17.11 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=MEIP&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=MEIP&exchange=NASDAQ&chart=1

Momenta Pharmaceuticals Inc

MNTA $14.68
-0.02 (-0.14%)

MNTA Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 1.37 Billion
MNTA Description

Momenta is a biotechnology company based in Cambridge, Mass. Using technology developed at the Massachusetts Institute of Technology, it focuses on the characterization and development of innovative and complex generic drug molecules. Its first product was a bioequivalent generic version of Lovenox, sold through a partnership with Novartis. The company received an approval for the first generic version of Copaxone in early 2015, and has other innovative drugs under development. http://www.momentapharma.com

MNTA Earnings

EPS -0.06 P/E Ratio 0.00
Previous Earnings Fri, Feb 22, 2019
Latest Earnings Thu, May 2, 2019 (In 8 days)

MNTA Dividend

Dividend --
Ex-Date --
Pay Date --
History --

MNTA Charts

$10.32
52 Week Range
$31.20
Dec 24, 2018
Jul 25, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

14.68 1.37 0.00 0.00 MNTA NASDAQ -0.14 31.15 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=MNTA&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=MNTA&exchange=NASDAQ&chart=1

Neos Therapeutics Inc

NEOS $2.29
-0.03 (-1.29%)

NEOS Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 100 Million
NEOS Description

Neos Therapeutics Inc is a pharmaceutical company, engaged in the development, manufacture, and commercialization of products for the treatment of attention deficit hyperactivity disorder (ADHD) using its drug delivery technologies. The product portfolio of the company includes Methylphenidate XR-ODT and Amphetamine XR oral suspension commonly prescribed medicine for the treatment of ADHD. In addition, it also manufactures and markets generic Tussionex, a hydrocodone polistirex and chlorpheniramine polistirex XR liquid suspension product indicated for the relief of cough. Geographically, it operates through United States and derives revenue through sale of products. http://www.neostx.com

NEOS Earnings

EPS -0.15 P/E Ratio 0.00
Previous Earnings Fri, Nov 9, 2018
Latest Earnings Thu, Mar 14, 2019 (41 days ago)

NEOS Dividend

Dividend --
Ex-Date --
Pay Date --
History --

NEOS Charts

$1.57
52 Week Range
$8.50
Dec 26, 2018
Apr 26, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

2.29 0.10 0.00 0.00 NEOS NASDAQ -1.29 19.90 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=NEOS&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=NEOS&exchange=NASDAQ&chart=1

Novartis AG Common Stock

NVS $78.35
+2.45 (3.23%)

NVS Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 174.26 Billion
NVS Description

Novartis AG develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total sales. http://www.novartis.com

NVS Earnings

EPS 0.52 P/E Ratio 15.59
Previous Earnings Wed, Apr 24, 2019
Latest Earnings Thu, Jul 18, 2019 (In 85 days)

NVS Dividend

Dividend --
Ex-Date --
Pay Date --
History --

NVS Charts

$63.60
52 Week Range
$84.40
Jun 27, 2018
Mar 29, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

78.35 174.26 15.59 0.00 NVS NYSE 3.23 6.17 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=NVS&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=NVS&exchange=NYSE&chart=1

Oasmia Pharmaceutical AB - American Depositary Shares

OASM $2.15
-0.10 (-4.44%)

OASM Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 180 Million
OASM Description

Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company which develops, manufactures, markets and sells a new generation of drugs within human and veterinary oncology. It focuses on the development of manufacturing activity of novel formulations based on cytostatic which shows improved properties, a reduced side-effect profile, and an expanded therapeutic area. The products and product candidates utilize a proprietary, nanoparticle formulation technology that is designed to facilitate the administration of intravenously-delivered active pharmaceutical ingredients, without the addition of toxic solvents. http://www.oasmia.com

OASM Earnings

EPS -0.39 P/E Ratio 0.00
Previous Earnings Fri, Mar 1, 2019
Latest Earnings Wed, Jun 5, 2019 (In 42 days)

OASM Dividend

Dividend --
Ex-Date --
Pay Date --
History --

OASM Charts

$1.23
52 Week Range
$5.35
May 30, 2018
Sep 26, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

2.15 0.18 0.00 0.00 OASM NASDAQ -4.44 -26.62 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=OASM&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=OASM&exchange=NASDAQ&chart=1

OPKO Health Inc

OPK $2.35
-0.06 (-2.49%)

OPK Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 1.42 Billion
OPK Description

Opko Health is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. Opko also owns a specialty active pharmaceutical ingredients manufacturer in Israel. The company's bio-reference testing business consists of routine testing and esoteric testing. Routine tests measure various health parameters, such as the functions of the heart, kidney, liver, thyroid, and other organs. https://www.opko.com

OPK Earnings

EPS -0.13 P/E Ratio 0.00
Previous Earnings Fri, Nov 9, 2018
Latest Earnings Wed, Feb 27, 2019 (56 days ago)

OPK Dividend

Dividend --
Ex-Date --
Pay Date --
History --

OPK Charts

$2.34
52 Week Range
$6.29
Apr 22, 2019
Jul 17, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

2.35 1.42 0.00 0.00 OPK NASDAQ -2.49 -28.57 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=OPK&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=OPK&exchange=NASDAQ&chart=1

OptiNose Inc

OPTN $9.92
-0.21 (-2.07%)

OPTN Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap --
OPTN Description

OptiNose Inc is a US-based specialty pharmaceutical company which focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. The lead product of the company, XHANCE nasal spray, which utilizes proprietary breath powered exhalation delivery system, to deliver a topically-acting and potent anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids. The pipeline products of the company include XHANCE, OPN-300, OPN-021, and AVP-825. http://www.optinose.com

OPTN Earnings

EPS -0.64 P/E Ratio 0.00
Previous Earnings Tue, Nov 13, 2018
Latest Earnings Wed, Mar 6, 2019 (49 days ago)

OPTN Dividend

Dividend --
Ex-Date --
Pay Date --
History --

OPTN Charts

$5.84
52 Week Range
$29.76
Dec 20, 2018
Jul 9, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

9.92 0.00 0.00 0.00 OPTN NASDAQ -2.07 45.24 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=OPTN&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=OPTN&exchange=NASDAQ&chart=1

Phibro Animal Health Corp

PAHC $33.15
+0.06 (0.18%)

PAHC Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 1.35 Billion
PAHC Description

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the US and other international countries. http://www.pahc.com

PAHC Earnings

EPS 0.37 P/E Ratio 20.83
Previous Earnings Wed, Feb 6, 2019
Latest Earnings Mon, May 6, 2019 (In 12 days)

PAHC Dividend

Dividend 1.45% / $0.48
Ex-Date Tue, Nov 27, 2018 (148 days ago)
Pay Date Wed, Dec 19, 2018
History 18 Payments (Quarterly)

PAHC Charts

$28.71
52 Week Range
$53.50
Mar 7, 2019
Aug 27, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

33.15 1.35 20.83 1.45 PAHC NASDAQ 0.18 3.89 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=PAHC&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=PAHC&exchange=NASDAQ&chart=1

Pacira Pharmaceuticals Inc

PCRX $40.68
+1.53 (3.91%)

PCRX Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 1.52 Billion
PCRX Description

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company have launched EXPAREL which utilizes DepoFoam, a product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. http://www.pacira.com

PCRX Earnings

EPS 0.20 P/E Ratio 0.00
Previous Earnings Thu, Nov 1, 2018
Latest Earnings Thu, Feb 28, 2019 (55 days ago)

PCRX Dividend

Dividend --
Ex-Date --
Pay Date --
History --

PCRX Charts

$30.55
52 Week Range
$52.16
Jun 27, 2018
Nov 1, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

40.68 1.52 0.00 0.00 PCRX NASDAQ 3.91 -2.66 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=PCRX&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=PCRX&exchange=NASDAQ&chart=1

PetIQ Inc

PETQ $30.69
-0.01 (-0.03%)

PETQ Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 850 Million
PETQ Description

PetIQ Inc is a manufacturer and distributor of health and wellness products for dogs and cats. The company offers veterinarian-grade pet Rx medications, OTC flea and tick preventatives, vitamins treats, nutritional supplements, and hygiene products. The group operates in two segments namely the Product and Service segments. It also provides third-party products to retailers which for a long time were primarily available from veterinary clinics only. Its proprietary brands include Advecta, Betsy Farms, Mimi's Market, PetAction and TruProfen. It operates mainly in the United States, Canada, and Europe. http://www.petiq.com

PETQ Earnings

EPS -0.16 P/E Ratio 0.00
Previous Earnings Tue, Nov 13, 2018
Latest Earnings Mon, Mar 11, 2019 (44 days ago)

PETQ Dividend

Dividend --
Ex-Date --
Pay Date --
History --

PETQ Charts

$17.91
52 Week Range
$42.36
May 21, 2018
Sep 13, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

30.69 0.85 0.00 0.00 PETQ NASDAQ -0.03 29.38 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=PETQ&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=PETQ&exchange=NASDAQ&chart=1

ProPhase Labs Inc

PRPH $3.00
-0.01 (-0.33%)

PRPH Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 30 Million
PRPH Description

ProPhase Labs Inc is a manufacturer and distributor of homeopathic and health products. It is engaged in the research, development, manufacture, distribution, marketing and sale of over-the-counter consumer healthcare products, dietary supplements and other remedies in the United States. Its products include TK supplements such as Legendz XL, Triple Edge XL, a daily energy and stamina booster, and Super ProstaFlow to support prostate and urinary health. http://www.prophaselabs.com

PRPH Earnings

EPS -0.04 P/E Ratio 0.00
Previous Earnings Mon, Aug 20, 2018
Latest Earnings Tue, Mar 26, 2019 (29 days ago)

PRPH Dividend

Dividend --
Ex-Date Wed, Jan 9, 2019 (105 days ago)
Pay Date Thu, Jan 24, 2019
History 2 Payments (Quarterly)

PRPH Charts

$2.70
52 Week Range
$5.41
Mar 11, 2019
May 15, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

3.00 0.03 0.00 0.00 PRPH NASDAQ -0.33 -7.69 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=PRPH&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=PRPH&exchange=NASDAQ&chart=1

Pernix Therapeutics Holdings Inc

PTX $0.21
-0.01 (-4.55%)

PTX Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap --
PTX Description

Pernix Therapeutics Holdings Inc is a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription drugs. It aims at underserved therapeutic areas, such as central nervous system, including neurology, pain, and psychiatry. Its products include Treximet used to treat acute migraine; Zohydro ER with BeadTek, an extended-release opioid agonist indicated used in case of severe pain; Silenor for the treatment of insomnia characterized by difficulty with sleep maintenance, and Khedezla for major depressive disorder. Geographically all the operations are functioned though the United States, however also has a business presence in international market. http://www.pernixtx.com

PTX Earnings

EPS -0.89 P/E Ratio 0.00
Previous Earnings --
Latest Earnings Thu, Aug 9, 2018 (258 days ago)

PTX Dividend

Dividend --
Ex-Date --
Pay Date --
History --

PTX Charts

$0.21
52 Week Range
$2.78
New Low Today
May 17, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

0.21 0.00 0.00 0.00 PTX NASDAQ -4.55 -51.16 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=PTX&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=PTX&exchange=NASDAQ&chart=1

Radius Health Inc

RDUS $21.45
-0.14 (-0.65%)

RDUS Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 960 Million
RDUS Description

Radius Health Inc is an integrated biopharmaceutical company. It develops and commercializes endocrine therapeutics in the areas of osteoporosis and oncology. The company's product, TYMLOS, is for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy. The product pipeline of the company includes Abaloparatide-patch for the treatment of postmenopausal women with osteoporosis, Elacestrant, and RAD140. It primarily operates the business in the United States of America and generates key revenue from the sales of TYMLOS. https://www.radiuspharm.com

RDUS Earnings

EPS -0.90 P/E Ratio 0.00
Previous Earnings Thu, Nov 1, 2018
Latest Earnings Thu, Feb 28, 2019 (55 days ago)

RDUS Dividend

Dividend --
Ex-Date --
Pay Date --
History --

RDUS Charts

$13.35
52 Week Range
$33.45
Dec 24, 2018
May 14, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

21.45 0.96 0.00 0.00 RDUS NASDAQ -0.65 27.30 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=RDUS&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=RDUS&exchange=NASDAQ&chart=1

Dr. Reddy's Laboratories Ltd Common Stock

RDY $40.88
-0.01 (-0.02%)

RDY Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 6.70 Billion
RDY Description

With headquarters in India, Dr. Reddy's Laboratories develops and manufactures generic pharmaceuticals. The firm operates in three divisions: global generics, proprietary products, and active chemical ingredients. The global generics and pharmaceutical services and active ingredients segments make up most of the company's revenue at about 76% and 19%, respectively. About 82% of Dr. Reddy's sales are based outside of India, with approximately 48% from the United States. http://www.drreddys.com

RDY Earnings

EPS 30.16 P/E Ratio 26.17
Previous Earnings Fri, Feb 1, 2019
Latest Earnings Fri, May 17, 2019 (In 23 days)

RDY Dividend

Dividend 0.72% / $0.29
Ex-Date Fri, Jul 13, 2018 (285 days ago)
Pay Date Thu, Aug 9, 2018
History 20 Payments (Annually)

RDY Charts

$28.49
52 Week Range
$41.11
May 31, 2018
Apr 2, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

40.88 6.70 26.17 0.72 RDY NYSE -0.02 8.81 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=RDY&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=RDY&exchange=NYSE&chart=1

Rockwell Medical Inc

RMTI $4.65
-0.08 (-1.69%)

RMTI Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 260 Million
RMTI Description

Rockwell Medical Inc is a US-based fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease with its products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The company's drug products are Triferic and Calcitriol. Triferic is a therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients with chronic kidney disease. It replaces the ongoing iron loss that occurs to patients during every hemodialysis treatment, via dialysate. Calcitriol is a generic drug for treating secondary hyperparathyroidism in dialysis patients. The company operates in one segment of hemodialysis market which involves the manufacture, sale, and distribution of hemodialysis products. http://www.rockwellmed.com

RMTI Earnings

EPS -0.17 P/E Ratio 0.00
Previous Earnings Fri, Nov 9, 2018
Latest Earnings Thu, Mar 14, 2019 (41 days ago)

RMTI Dividend

Dividend --
Ex-Date --
Pay Date --
History --

RMTI Charts

$2.26
52 Week Range
$6.42
Dec 31, 2018
Mar 20, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

4.65 0.26 0.00 0.00 RMTI NASDAQ -1.69 67.27 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=RMTI&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=RMTI&exchange=NASDAQ&chart=1

Retrophin Inc

RTRX $19.68
-0.03 (-0.15%)

RTRX Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 820 Million
RTRX Description

Retrophin Inc serves in the healthcare sector based in the United States. As a pharmaceutical products manufacturer, it develops drugs to treat serious and rare diseases. Its suite of drug candidates includes Chenodal, to combat gallstones; Cholbam, which is approved for the treatment of bile acid synthesis disorders and Thiola, which addresses kidney stone formation. http://www.retrophin.com

RTRX Earnings

EPS -0.18 P/E Ratio 0.00
Previous Earnings Thu, Nov 1, 2018
Latest Earnings Tue, Feb 26, 2019 (57 days ago)

RTRX Dividend

Dividend --
Ex-Date --
Pay Date --
History --

RTRX Charts

$19.67
52 Week Range
$32.15
New Low Today
Sep 4, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

19.68 0.82 0.00 0.00 RTRX NASDAQ -0.15 -13.19 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=RTRX&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=RTRX&exchange=NASDAQ&chart=1

SCYNEXIS Inc

SCYX $1.72
+0.02 (1.18%)

SCYX Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 90 Million
SCYX Description

SCYNEXIS Inc is drug development company which focuses on the development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. It is engaged in developing lead product candidate, SCY-078 which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The SCY-078 is a novel and structurally distinct triterpenoid glucan synthase inhibitor which is effective in vitro and in vivo against a broad range of Candida and Aspergillus species, including drug-resistant strains. http://www.scynexis.com

SCYX Earnings

EPS 0.06 P/E Ratio 0.00
Previous Earnings Tue, Nov 13, 2018
Latest Earnings Thu, Mar 14, 2019 (41 days ago)

SCYX Dividend

Dividend --
Ex-Date --
Pay Date --
History --

SCYX Charts

$0.38
52 Week Range
$2.01
Dec 21, 2018
Jul 12, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

1.72 0.09 0.00 0.00 SCYX NASDAQ 1.18 218.52 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=SCYX&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=SCYX&exchange=NASDAQ&chart=1

Synergy Pharmaceuticals Inc

SGYP $0.05
+0.02 (66.67%)

SGYP Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 10 Million
SGYP Description

Synergy Pharmaceuticals Inc functions in the healthcare sector based in the United States. It focusses on developing therapies to combat gastrointestinal diseases. The company's basic ingredient is the uroguanylin analog, which it employs in its products candidates such as plecanatide and dolcanatide. Plecanatide is a once-daily tablet, which addresses chronic idiopathic constipation and the irritable bowel syndrome. Dolcanatide is meant to cure inflammatory bowel disease by aiding the process of digestive breakdown. http://www.synergypharma.com

SGYP Earnings

EPS -0.14 P/E Ratio 0.00
Previous Earnings Tue, Aug 7, 2018
Latest Earnings Thu, Nov 8, 2018 (167 days ago)

SGYP Dividend

Dividend --
Ex-Date --
Pay Date --
History --

SGYP Charts

$0.03
52 Week Range
$2.06
New Low Today
Jun 20, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

0.05 0.01 0.00 0.00 SGYP NASDAQ 66.67 -77.27 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=SGYP&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=SGYP&exchange=NASDAQ&chart=1

Solid Biosciences Inc

SLDB $9.32
+0.07 (0.65%)

SLDB Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 330 Million
SLDB Description

Solid Biosciences Inc is a life science company. It is engaged in manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. Its lead product candidate, the SGT-001, is a gene transfer under development to restore functional dystrophin protein expression in patients' muscles. The company's pipeline products are the SB-001 and solid suit. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices. In the assistive device program, the company focuses on producing a wearable assistive device for patients with DMD. http://www.solidbio.com

SLDB Earnings

EPS -0.64 P/E Ratio 0.00
Previous Earnings Tue, Nov 13, 2018
Latest Earnings Wed, Mar 13, 2019 (42 days ago)

SLDB Dividend

Dividend --
Ex-Date --
Pay Date --
History --

SLDB Charts

$7.19
52 Week Range
$51.70
Feb 7, 2019
Sep 20, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

9.32 0.33 0.00 0.00 SLDB NASDAQ 0.65 -67.63 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=SLDB&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=SLDB&exchange=NASDAQ&chart=1

Sonoma Pharmaceuticals, Inc. - Common Stock

SNOA $0.92
0.00 (0.00%)

SNOA Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 10 Million
SNOA Description

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing and commercializing differentiated therapies to patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes and others. The majority of the company revenue comes from the United States. http://www.sonomapharma.com

SNOA Earnings

EPS -0.26 P/E Ratio 0.00
Previous Earnings --
Latest Earnings --

SNOA Dividend

Dividend --
Ex-Date --
Pay Date --
History --

SNOA Charts

$0.65
52 Week Range
$4.01
Dec 24, 2018
Jun 13, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

0.92 0.01 0.00 0.00 SNOA NASDAQ 0.00 19.48 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=SNOA&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=SNOA&exchange=NASDAQ&chart=1

Supernus Pharmaceuticals Inc

SUPN $37.07
-0.21 (-0.56%)

SUPN Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 1.89 Billion
SUPN Description

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. https://www.supernus.com

SUPN Earnings

EPS 0.50 P/E Ratio 18.03
Previous Earnings Tue, Nov 6, 2018
Latest Earnings Tue, Feb 26, 2019 (57 days ago)

SUPN Dividend

Dividend --
Ex-Date --
Pay Date --
History --

SUPN Charts

$30.84
52 Week Range
$59.85
Dec 24, 2018
Jun 29, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

37.07 1.89 18.03 0.00 SUPN NASDAQ -0.56 13.12 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=SUPN&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=SUPN&exchange=NASDAQ&chart=1

Taro Pharmaceutical Industries Ltd

TARO $107.52
+1.88 (1.78%)

TARO Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 4.10 Billion
TARO Description

Taro Pharmaceutical Industries Ltd produces, researches, develops and markets pharmaceutical products. Its primary focus includes semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets. It is engaged in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. It develops, manufactures and markets Rx and OTC pharmaceutical products in the United States, Canada and Israel. http://www.taro.com

TARO Earnings

EPS 2.40 P/E Ratio 13.19
Previous Earnings Mon, Nov 5, 2018
Latest Earnings Wed, Feb 6, 2019 (77 days ago)

TARO Dividend

Dividend --
Ex-Date --
Pay Date --
History 9 Payments (Annually)

TARO Charts

$78.25
52 Week Range
$120.59
Dec 21, 2018
Jun 6, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

107.52 4.10 13.19 0.00 TARO NYSE 1.78 25.07 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=TARO&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=TARO&exchange=NYSE&chart=1

Tricida Inc

TCDA $33.23
+0.77 (2.38%)

TCDA Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 1.54 Billion
TCDA Description

Tricida Inc is a late-stage pharmaceutical company. It is engaged in the development of novel therapeutics to address renal, metabolic and cardiovascular disease. The primary area of focus is to slow the progression of chronic kidney disease through the treatment of metabolic acidosis. https://www.tricida.com

TCDA Earnings

EPS -0.66 P/E Ratio 0.00
Previous Earnings Thu, Nov 8, 2018
Latest Earnings Thu, Mar 28, 2019 (27 days ago)

TCDA Dividend

Dividend --
Ex-Date --
Pay Date --
History --

TCDA Charts

$19.96
52 Week Range
$39.35
Jan 29, 2019
Sep 10, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

33.23 1.54 0.00 0.00 TCDA NASDAQ 2.38 41.87 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=TCDA&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=TCDA&exchange=NASDAQ&chart=1

Teligent Inc

TLGT $0.99
0.00 (0.00%)

TLGT Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 40 Million
TLGT Description

Teligent Inc is a specialty generic pharmaceutical company. Teligent develops, manufactures, and sells (under its own label) topical, injectable, complex, and ophthalmic pharmaceutical products in the U.S. and Canada. The product portfolio consists of hospital-based sterile injectable products and topical products (creams like Synalar and Spectazole; lotions like Kenalog; ointments like Topicort and Kenalog; and topical solutions like Pennsaid and Xylocaine). The company also offers services to the pharmaceutical, over-the-counter, and cosmetic markets. http://www.teligent.com

TLGT Earnings

EPS -0.27 P/E Ratio 0.00
Previous Earnings Tue, Nov 13, 2018
Latest Earnings Mon, Mar 18, 2019 (37 days ago)

TLGT Dividend

Dividend --
Ex-Date --
Pay Date --
History --

TLGT Charts

$0.82
52 Week Range
$4.46
Apr 18, 2019
Aug 22, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

0.99 0.04 0.00 0.00 TLGT NASDAQ 0.00 -25.00 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=TLGT&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=TLGT&exchange=NASDAQ&chart=1

Tilray Inc

TLRY $51.67
+1.41 (2.81%)

TLRY Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 4.74 Billion
TLRY Description

Tilray Inc is engaged in the sale and development of medical cannabis. Geographically, the company derives the majority of its revenue from Canada. The product categories of the company include dried cannabis which includes whole flower and ground flower, and cannabis extract which include full spectrum and purified oil drops and capsules. http://www.tilray.com

TLRY Earnings

EPS -0.33 P/E Ratio 0.00
Previous Earnings Tue, Nov 13, 2018
Latest Earnings Mon, Mar 18, 2019 (37 days ago)

TLRY Dividend

Dividend --
Ex-Date --
Pay Date --
History --

TLRY Charts

$22.10
52 Week Range
$214.06
Jul 31, 2018
Sep 19, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

51.67 4.74 0.00 0.00 TLRY NASDAQ 2.81 -26.67 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=TLRY&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=TLRY&exchange=NASDAQ&chart=1

TherapeuticsMD Inc

TXMD $4.19
+0.01 (0.24%)

TXMD Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 1.02 Billion
TXMD Description

TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusively for women. The company intends to commercialize advanced hormone therapy pharmaceutical products. TherapeuticsMD's drug candidates that have completed clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and discomfort. The company relies on third parties for the production of clinical and commercial quantities of its drug candidates. http://www.therapeuticsmd.com

TXMD Earnings

EPS -0.17 P/E Ratio 0.00
Previous Earnings Wed, Nov 7, 2018
Latest Earnings Thu, Feb 21, 2019 (62 days ago)

TXMD Dividend

Dividend --
Ex-Date --
Pay Date --
History --

TXMD Charts

$3.56
52 Week Range
$7.42
Dec 20, 2018
Jun 8, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

4.19 1.02 0.00 0.00 TXMD NASDAQ 0.24 7.99 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=TXMD&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=TXMD&exchange=NASDAQ&chart=1

Shineco Inc

TYHT $1.24
+0.06 (4.21%)

TYHT Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 30 Million
TYHT Description

Shineco Inc through its subsidiaries, produces, distributes, and sells health and well-being focused plantbased products under the Tenethealth and Tenet Bojian brands in China. It operates through three segments: developing, manufacturing and distributing of specialized fabrics, textile products and other by-products derived from an indigenous Chinese plant called Apocynum Venetum;, Processing and distributing of traditional Chinese medicinal herbal products, as well as other pharmaceutical products; and Processing and distributing of green and organic agricultural produce, as well as growing and cultivating of Chinese Yew trees (Agricultural products). Majority of the revenue for the group is derived through sale of Agricultural products. http://www.tyht.com

TYHT Earnings

EPS 0.03 P/E Ratio 6.68
Previous Earnings --
Latest Earnings --

TYHT Dividend

Dividend --
Ex-Date --
Pay Date --
History --

TYHT Charts

$0.44
52 Week Range
$2.03
Feb 13, 2019
May 18, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

1.24 0.03 6.68 0.00 TYHT NASDAQ 4.21 96.72 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=TYHT&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=TYHT&exchange=NASDAQ&chart=1

Veru Inc. - Common Stock

VERU $1.41
0.00 (0.00%)

VERU Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 90 Million
VERU Description

Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility and novel chemotherapies for a variety of cancers. The company currently operates in two reporting segments: Commercial and Research and Development. https://www.verupharma.com

VERU Earnings

EPS -0.03 P/E Ratio 0.00
Previous Earnings Thu, Dec 13, 2018
Latest Earnings Wed, Feb 13, 2019 (70 days ago)

VERU Dividend

Dividend --
Ex-Date --
Pay Date --
History 18 Payments (Quarterly)

VERU Charts

$1.20
52 Week Range
$2.29
Feb 25, 2019
Jun 15, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

1.41 0.09 0.00 0.00 VERU NASDAQ 0.00 0.71 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=VERU&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=VERU&exchange=NASDAQ&chart=1

Zogenix Inc

ZGNX $38.41
+1.02 (2.73%)

ZGNX Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 1.55 Billion
ZGNX Description

Zogenix Inc is engaged in developing and commercializing therapeutic solutions for people living with serious and life-threatening rare CNS disorders and medical conditions. Its product candidate includes ZX008, low-dose fenfluramine for the treatment of Dravet syndrome, LGS, and potentially other rare and catastrophic epilepsy disorders. http://www.zogenix.com

ZGNX Earnings

EPS -0.53 P/E Ratio 0.00
Previous Earnings Thu, Nov 8, 2018
Latest Earnings Thu, Feb 28, 2019 (55 days ago)

ZGNX Dividend

Dividend --
Ex-Date --
Pay Date --
History --

ZGNX Charts

$34.16
52 Week Range
$61.35
Dec 21, 2018
Jul 13, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

38.41 1.55 0.00 0.00 ZGNX NASDAQ 2.73 0.68 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ZGNX&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ZGNX&exchange=NASDAQ&chart=1

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy

/* Handling these symbols $DJI $DJT $DJU BF.B BRK.A BRK.B */ /* Handling these symbols $DJI $DJT $DJU BF.B BRK.A BRK.B */